Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. - Wikidata - wikimedia - TriplyDB

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q36839777

about

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Genetic variants in hormone-related genes and risk of breast cancer.Two decades after BRCA: setting paradigms in personalized cancer care and prevention Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women Fine mapping of 14q24.1 breast cancer susceptibility locus Breast Cancer Risk - Genes, Environment and Clinics.Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X.Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis.Associations of two common genetic variants with breast cancer risk in a chinese population: a stratified interaction analysis Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium Ten modifiers of BRCA1 penetrance validated in a Norwegian series Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk Genetic susceptibility to triple-negative breast cancer.Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.Genomic Biomarkers for Breast Cancer Risk.Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.Common breast cancer risk variants in the post-COGS era: a comprehensive review.Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers.Analyzing 395,793 samples shows significant association between rs999737 polymorphism and breast cancer.Association of three single nucleotide polymorphisms of ESR1with breast cancer susceptibility: a meta-analysis.ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.Common Genetic Variation and Breast Cancer Risk - Past, present, and future.Polymorphisms of long non-coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population.

P2860

Q27008356-A5D40B52-6C21-43DA-B4A7-80753A52F886 Q31001228-58905D4B-955D-4934-A94A-A4CF1AF51C79 Q31082788-07FEE93B-E193-4E08-9EAE-0DCFA8652139 Q31126135-6A94DEE4-214C-4E0D-BCC5-1643BCA577B5 Q33820594-D4B6B309-9E24-45CC-BF27-1475D5A4D982 Q33845209-09F823AA-ED54-433D-A849-795B51D1EBB4 Q34155371-C5CD5057-FDB6-47DA-BDE6-E5ABA108D94F Q34158088-52D52765-81D2-4942-869B-ACCEDE30424C Q34201805-8AC2ABC7-AD01-4E1B-96B9-704EF2EE7BAF Q34213403-62E2156A-6F2E-4846-868B-0D5CD8CDBF3D Q34269998-1E2B6A56-7441-4B94-87EB-740DCFEF6AD7 Q34339960-23FF03A6-4B69-4C87-8AAB-8E720B204592 Q34526153-DB4D257A-8357-45CC-9939-F40625A0F7D6 Q34757714-EA6E0764-E139-45A8-AF61-F0C775F2CF69 Q34778648-C235AB14-312D-448F-A5FE-0F11736C3D65 Q34973879-2A549D2F-5367-44A4-A831-1DB9C1E92671 Q34973918-C5637EC2-B8C6-4D9E-B78B-98D65AE84EE7 Q35532898-2D73EE42-9E97-4E95-8540-F3D4D2AF112C Q35686538-1AFC35B7-0F56-4010-900A-B911597CE4A9 Q35870067-005D41F0-35F8-4EC6-8318-877DB99AAFA2 Q35889575-FE1371A0-1D0C-4F96-AEDE-ECE44F3F6DAA Q35940158-28BFF607-CBA4-42F5-A423-A863F8914B0A Q36280191-D7385E2F-E525-4F7D-907F-5142B12A098D Q36352389-1E7F7192-D60A-4130-9E20-E448B32E3AB6 Q36393232-859739D5-5A69-4541-90EE-C00E92E11D90 Q36720814-AAF205EF-F573-4056-A357-31D31CD5AF29 Q36846498-9E85AF81-268E-497A-AC78-1EDC14AAB75A Q37122297-F1887BF2-E051-4AF3-942D-CE1A3C9C5764 Q37242239-73E5A99C-0D53-45B8-A3C4-0335C2E47DB0 Q37660589-405D25DA-B213-4689-BCC0-EC650600DC19 Q37690575-914E12FA-FEA1-4434-BA14-04B6C966C3FC Q37996438-0CD6C3C9-346B-4437-A9B8-3648D557E16A Q39210546-EC0A5F49-8797-4D1C-8216-EB586AEE5C37 Q42219383-6CCDC205-84C2-4E9B-8F4F-E953B28DCDD3 Q42367688-117141DD-33B9-4B41-BD61-D9265725860E Q43624639-1B58846D-1EEB-4CF8-8A85-2862568C27D3 Q44680094-E78E7A91-BD44-4629-93FC-3B9A76776B7B Q46070393-7565C1FC-726C-4B25-B421-E95D822AAC7E Q47703662-E72EA564-CEBC-40B7-A55D-B848216F283A Q50004504-BD4D46E2-D55F-4C07-BCAA-6329475E76CF

P2860

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

http://www.wikidata.org/entity/Q36839777

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en-gb

type

label

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en-gb

prefLabel

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en-gb

P1433

Q36839777-03AD5E5E-B619-4B07-8976-BE65B78EAA6A

P1476

Q36839777-A54AD4A9-085C-463C-93E0-BE7CEE149FC2

P2093

Q36839777-0B2D349E-2C62-47B5-BE4D-49226CE3F3B1

Q36839777-0D6D75A9-453A-446F-B480-54F22CEAD2C2

Q36839777-0F56B6F1-7210-4ECA-905D-E81DA912B3A1

Q36839777-13A3B2D9-E371-4824-98FD-A60E6BF38A64

Q36839777-14E28686-9CAC-4409-9B8D-21EAF1C38A1A

Q36839777-161B9423-622B-4F6E-A8C2-BC068C780BF2

Q36839777-1A9363DD-B9B7-4CB0-94D7-B86F901F586B

Q36839777-1CD69DB7-0480-4699-B2CD-8FE2A64832B3

Q36839777-1DB19AC3-EEE3-4FE3-8892-7AEB5790E6BD

Q36839777-1DC30CD1-D3F6-462C-8A87-95FB428E53CE

P2860

Q36839777-0095EA5A-6B0B-4D06-9FFC-DBDC102DD689

Q36839777-1EAFE415-F825-4B8D-A00B-D831CA5AFEA4

Q36839777-20672FF7-DE04-4BCC-95E7-2981013EBFC1

Q36839777-27585F4A-B5A8-4113-9ECE-29A979F93E04

Q36839777-2C09309E-3B6D-4D32-9319-1F2E5B989326

Q36839777-3EFBE210-E027-44B1-B2BA-F9EF39D39C1E

Q36839777-41C572C6-527D-44F6-8B9A-E9FC9B1F5AED

Q36839777-4269E90A-1551-4F5C-8C2C-9B81F97F027C

Q36839777-50665D83-5D90-464E-B75C-FEBABD69EE2E

Q36839777-5297C43B-7021-4BA5-929B-7DC4BB9C4DE0

P304

Q36839777-29AD0C63-4281-40B3-BAE7-510E65B28221

P31

Q36839777-58FEDA97-1088-4683-AC6E-21338972ABE9

P356

Q36839777-9685F4F9-FC5C-49C4-9411-2E41F27FBD4A

P433

Q36839777-51188DC4-6CBC-4F9C-B819-AD761A255E19

P478

Q36839777-8FC67563-CABE-4DBE-9D59-B63A048BE633

P50

Q36839777-00E25E64-312C-46B9-B968-A664000806F1

Q36839777-0A0FC636-BEC0-4895-85A1-7C27FF91D4E8

Q36839777-0C9D4821-0F0E-4001-8A14-C3BC8673113F

Q36839777-0FA6EBB4-A3CE-46F5-9DB2-E39BDF0F8E11

Q36839777-1E06F0E2-1D2E-4B01-9EA8-7D25EF55004C

Q36839777-1EA67DE2-D555-4219-96AA-69A0E4994E39

Q36839777-1F006783-0419-4435-88C5-C89072194695

Q36839777-21789005-1D7C-4F96-A22A-E79BCE162665

Q36839777-23D65332-4CAD-4A86-B4CC-658FF1FE4627

Q36839777-23D6A65B-A93B-4B05-A3E4-1347587F8D15

P577

Q36839777-822568F9-829B-4C52-8B0D-60C51D44D38B

P5875

Q36839777-E744046F-9974-4FDC-8760-40E0ABE5DE37

P698

Q36839777-CBEA28A7-A70B-4C9A-A655-C69C40F4D53D

P932

Q36839777-35C940F1-F7DC-4C9D-A2F2-C72F76257E40

P356

P1433

Human Molecular Genetics

P1476

Common alleles at 6q25.1 and 1 ...... 1 and BRCA2 mutation carriers.

@en

P2093

Alexander Miron

http://www.w3.org/2001/XMLSchema#string

Andrew Godwin

http://www.w3.org/2001/XMLSchema#string

Andrew Lee

http://www.w3.org/2001/XMLSchema#string

Ania Jakubowska

http://www.w3.org/2001/XMLSchema#string

Aniko Bozsik

http://www.w3.org/2001/XMLSchema#string

Anne Catharina Dressler

http://www.w3.org/2001/XMLSchema#string

Barbara Pasini

http://www.w3.org/2001/XMLSchema#string

Beatrice Melin

http://www.w3.org/2001/XMLSchema#string

Bella Kaufman

http://www.w3.org/2001/XMLSchema#string

Beth Y Karlan

http://www.w3.org/2001/XMLSchema#string

P2860

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

Genome-wide association study identifies novel breast cancer susceptibility loci

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Ovarian steroid hormones: what's hot in the stem cell pool?

P304

3304-3321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDR226

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Stoppa-Lyonnet

Georgia Chenevix-Trench

Rita Schmutzler

Kristiina Aittomäki

Heli Nevanlinna

P577

2011-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51147245

http://www.w3.org/2001/XMLSchema#string

P698

21593217

http://www.w3.org/2001/XMLSchema#string

P932

3652640

http://www.w3.org/2001/XMLSchema#string